US Pre-Market SEC Filings Roundup — April 21, 2026

21-04-2026

OUTFRONT Media Inc. filed Definitive Additional Materials (DEFA14A) on April 21, 2026, pursuant to Section 14(a) of the Securities Exchange Act of 1934 under Schedule 14A. The filing indicates no fee was required and serves as soliciting material supplementing the proxy process. No substantive proposals, financial data, or voting matters are detailed in the provided header.

• ·Filing Type: DEFA14A (Definitive Additional Materials)
• ·No fee required for filing

21-04-2026

Synchrony Financial furnished its Monthly Charge-Off and Delinquency Statistics as of and for each of the thirteen months ended March 31, 2026, in Exhibit 99.1 under Item 7.01 Regulation FD Disclosure. The company intends to continue providing these statistics monthly, with the last month of each calendar quarter furnished alongside quarterly financial results announcements. This information is not deemed 'filed' for liability purposes.

• ·Filing date: April 21, 2026
• ·Statistics cover thirteen months ended March 31, 2026
• ·Securities registered on New York Stock Exchange

21-04-2026

UnitedHealth Group reported Q1 2026 revenues of $111.7 billion, up 2% YoY from $109.6 billion, with UnitedHealthcare revenues growing 2% to $86.3 billion and operating margin expanding 40 basis points to 6.6%; however, Optum revenues dipped slightly to $63.7 billion from $63.9 billion with earnings declining to $3.3 billion from $3.9 billion, operating cost ratio rose to 13.8% from 12.4%, and earnings from operations fell to $9.0 billion from $9.1 billion. The company raised its full-year 2026 adjusted earnings outlook to greater than $18.25 per share, announced the acquisition of Alegeus Technologies (expected earnings neutral), completed the sale of Optum UK for $400 million in net proceeds, and plans to repurchase at least $2 billion in stock by end-Q2.

• ·Medical care ratio improved to 83.9% from 84.8% YoY (down 90 basis points).
• ·Days claims payable 48.6 (up from 45.5 YoY); days sales outstanding 21.6 (down from 22.3 YoY).
• ·Debt-to-capital ratio 42.9% as of March 31, 2026 (down from 44.6% YoY).
• ·UnitedHealthcare Medicare & Retirement seniors served declined by 965,000 in Q1 2026.
• ·UnitedHealthcare Community & State people served contracted by 220,000 in Q1 2026.
• ·Optum Rx adjusted scripts 383 million vs 408 million YoY.

21-04-2026

First United Corporation reported Q1 2026 GAAP net income of $6.7 million ($1.03 per diluted share), up from $5.8 million ($0.89 per diluted share) in both Q1 2025 and Q4 2025, driven by net interest income growth of $2.1 million YoY and net interest margin expansion to 3.83%. However, gross loans grew only $3.8 million QoQ to $1.5 billion amid elevated payoffs, with residential mortgages down $10.6 million and commercial & industrial loans down $30.8 million, while total assets declined $48.4 million to $2.0 billion. Deposits rose $15.5 million QoQ, led by $44.4 million in savings and money market growth, but provision expense increased to $0.9 million.

• ·Commercial loan pipeline $43.0M and unfunded commitments $43.0M as of March 31, 2026.
• ·Residential mortgage pipeline $17.5M and unfunded construction commitments $14.4M as of March 31, 2026.
• ·Cash dividend of $0.26 per common share declared in Q1 2026.
• ·Book value per share $31.84 at March 31, 2026, up from $31.33 at December 31, 2025.

21-04-2026

GHP Investment Advisors, Inc. filed its 13F-HR report on April 21, 2026, disclosing institutional equity holdings as of March 31, 2026, across 1637 positions with a total market value of $2430417630 thousand (approximately $2.43 trillion). Top holdings by reported value include Apple Inc. at 41188178 ($41.19 billion), Ametek Inc. at 17750712 ($17.75 billion), Analog Devices Inc. at 16290581 ($16.29 billion), Alphabet Inc. Cap Stk Cl C at 34330483 ($34.33 billion), and Berkshire Hathaway Inc. Del Cl B New at 26480299 ($26.48 billion). The report indicates sole voting authority on the vast majority of shares.

• ·Report filed as of April 21, 2026; signed by Sebrina Ivey on April 20, 2026
• ·Business address: 1290 N Broadway, Ste. 1100, Denver, CO 80203
• ·SEC file number: 028-12544
• ·Primarily sole investment discretion and voting authority across holdings

21-04-2026

On April 20, 2026, Eduardo Martins, M.D., D.Phil., retired as Chief Medical Officer of Sagimet Biosciences Inc., effective immediately, and will continue as an external scientific advisor. The company appointed Andreas Grauer, M.D., as the new Chief Medical Officer, effective the same date. Dr. Grauer previously served as CMO at Omeros Corporation (October 2023 to April 2026), Federation Bio (October 2021 to July 2023), and Corcept Therapeutics (March 2019 to August 2021), with prior roles at Amgen and Procter & Gamble Pharmaceuticals.

• ·Dr. Grauer held Vice President Global Development role at Amgen from December 2008 to December 2018.
• ·Dr. Grauer is an Associate Professor of Medicine at the University of Heidelberg Medical School.
• ·Series A Common Stock has $0.0001 par value per share and trades as SGMT on Nasdaq Global Market.

21-04-2026

Archimedes Tech SPAC Partners II Co. (ATII) entered into an Agreement and Plan of Merger on April 20, 2026, with Forge Nano, Inc., involving a reincorporation to Delaware as Forge Nano Holdings Inc., followed by two mergers to acquire Forge Nano for $1,200,000,000 in Closing Payment Shares at $10.00 per share. Forge Nano stockholders and convertible securities holders are eligible for up to 90,000,000 Earn-Out Shares over a 5-year period upon achieving stock price VWAP or revenue milestones of $400,000,000, $600,000,000, and $800,000,000. No current financial performance data is provided in the filing.

• ·ATII Warrants exercisable at $11.50 per share convert to Pubco Warrants on same terms.
• ·Forge Nano Options convert to Pubco Options adjusted by Applicable Per Share Merger Consideration and Equity Award Conversion Amount.
• ·Earn-Out Shares issued to Escrow at Closing and disbursed upon cumulative milestone achievement; convertible securities portion disbursed only upon exercise.
• ·Transaction includes Form S-4 registration statement with ATII proxy for shareholder approval.

21-04-2026

East West Ave Acquisition Corp., a blank-check SPAC structured as a limited liability company (CIK 0002100704), filed an S-1 registration statement on April 21, 2026, to register its initial public offering of units at $10.00 per unit. The filing details multiple pro forma scenarios for net proceeds from the offering and private unit sales, tangible book value calculations excluding certain offering costs, proceeds subject to redemption, and common share counts under varying over-allotment option exercises (none or full) and redemption levels (0%, 25%, 50%, 75%, or 100% of maximum). Private units are allocated to EastWaterAve LLC, NFRCapital Limited, and the Sponsor.

• ·Scenarios include over-allotment option exercised or not exercised.
• ·Redemption scenarios modeled at 25%, 50%, 75%, and 100% of maximum.
• ·Key reference dates: February 28, 2026 (pro forma as of) and April 20, 2026.

21-04-2026

JATT II Acquisition Corp, a blank check SPAC targeting healthcare and biotechnology sectors, announced the pricing of its $60,000,000 initial public offering of 6,000,000 ordinary shares at $10.00 per share, expected to begin trading on Nasdaq under ticker 'JATT' on April 17, 2026, with closing on April 20, 2026. Guggenheim Securities, LLC serves as sole book-running manager, with a 45-day option for underwriters to purchase up to 900,000 additional shares for over-allotments. The SEC declared the registration statement effective on April 16, 2026.

• ·Company sponsored by JATT Ventures II L.P. and focused on healthcare, biotechnology, life sciences, with emphasis on data-driven approaches like machine learning and computational biology.
• ·SEC registration statement declared effective on April 16, 2026.
• ·No specific business combination target selected as of announcement.

21-04-2026

James Reed Financial Services, Inc. filed its 13F-HR report as of March 31, 2026, disclosing 17 equity holdings with a total market value of $115,512,810,000. The portfolio is concentrated in ETFs such as iShares TR MSCI USA SZE FT ($26,146,082,000), Vanguard Index FDS Large CAP ETF ($25,621,737,000), J P MORGAN EXCHANGE TRADED F NASDAQ EQT PREM ($23,389,877,000), and individual stocks including Apple Inc ($1,134,188,000) and Microsoft Corp ($1,212,307,000). All positions are held solely with sole investment discretion and voting authority.

• ·Filing date: April 21, 2026
• ·Report period end: March 31, 2026
• ·All holdings reported as SH SOLE with sole voting authority (2474 shares 3M, 1034 Amazon, 905 Amgen, 4469 Apple, 586128 Capital Group, 2053 Exxon, 30413 Global X Artificial ETF, 163966 iShares MSCI USA, 421287 JPM EQ Prem, 1684 JPM Chase, 3275 Microsoft, 4488 NVIDIA, 3440 Progressive, 85734 Vanguard Large Cap, 52181 Vanguard Mid Cap, 430 Vanguard S&P 500, 2450 Vanguard Russell 1000 Growth)

21-04-2026

SmartHarvest Portfolios, LLC filed its 13F-HR on April 21, 2026, disclosing 387 equity holdings totaling $239706731 as of March 31, 2026. The portfolio features significant allocations to technology leaders including Apple Inc. ($13679989, 53903 shares), Amazon.com Inc. ($7328396, 35187 shares), Alphabet Inc. Class A ($7709021, 26808 shares), Alphabet Inc. Class C ($4555919, 15882 shares), and Broadcom Inc. ($5479743, 17705 shares). No period-over-period changes or performance data were provided in the filing.

• ·Filing covers period ending March 31, 2026
• ·Investment discretion: Sole voting authority on nearly all positions
• ·Portfolio includes diverse sectors with emphasis on technology, healthcare, and ETFs

21-04-2026

WJ Interests, LLC filed its 13F-HR on April 21, 2026, reporting total holdings of $260,401,199 across 20 positions as of March 31, 2026. The portfolio is diversified primarily in ETFs, with the largest positions in Return Stacked Stock and Bond RSSB ($44,396,410), Vanguard Total World Stock VT ($41,600,633), WisdomTree Intl Efficient Core NTSI ($30,219,939), and WisdomTree U.S. Efficient Core NTSX ($25,762,204). Smaller holdings include individual stocks such as IBM ($354,374), JP Morgan ($1,028,971), and Microsoft ($208,405).

• ·Filing as of date: April 20, 2026
• ·Filer address: 2333 Town Center Drive, Suite 100, Sugar Land, TX 77478
• ·All holdings reported as sole investment discretion with sole voting authority

21-04-2026

Battalion Oil Corporation filed an S-3 shelf registration statement on April 21, 2026, to enable future securities offerings, incorporating its 2025 10-K and recent 8-Ks. As of December 31, 2025, the company reported 59.7 MMBoe proved reserves (60% proved developed), average daily production of 12,096 Boe/d from Delaware Basin assets, and 39,968 net acres. Recent developments include the February 2026 closing of the $60.1 million West Quito Divestiture (reducing production by 15% and reserves by 10%) and a March 2026 private placement raising $15.0 million in gross proceeds.

• ·Reserves prepared using SEC-required pricing: WTI $66.01/Bbl, Henry Hub $3.39/MMBtu.
• ·Private placement shares priced at $5.50/share; pre-funded warrants at $5.4999/share with $0.0001 exercise price, expiring March 4, 2033.

21-04-2026

Drum Hill Capital, LLC disclosed 46 equity positions in its 13F-HR filing, with a total portfolio market value of $108883819 as of March 31, 2026. The largest holding is Vanguard Scottsdale Fds Short Term Treas at $14935135, followed by Telefonaktiebolaget LM Ericsson ADR at $7516538 and Newmont Corp at $8709795. All positions are held with sole discretionary authority and sole voting power, showing no shared control.

• ·Portfolio includes significant exposure to energy (e.g., Exxon Mobil Corp $3019270, TotalEnergies SE $3878296) and tech (e.g., Microsoft Corp $1630599, Apple Inc $876845) sectors.
• ·Filing date: April 21, 2026; period end: March 31, 2026.

21-04-2026

Titan Holdings Corp. (Pubco, wholly owned by Compass Digital Acquisition Corp. or CDAQ) is advancing a $303M business combination via SPAC merger with Key Mining Corp. (KMC), originally agreed on January 6, 2026, targeting listing by end of Q2 2026. The podcast highlights KMC's rutile Titanium project at Cerro Blanco in Chile (fully permitted with premium-grade concentrate potential), associated 440 liters/second desalination plant (with excess for third-party off-takers amid 4,000 liters/second unmet demand), and copper exploration adjacent to Zonia in Arizona. Key Mining emphasizes infrastructure advantages, critical minerals demand (market to $600B by 2032), and Inflation Reduction Act tailwinds, with post-deSPAC bankable feasibility study for Titanium expected in 9 months (March/April 2027).

• ·Titanium project acquired via tax sale and negotiation in late 2022; fully permitted for mine, mill, and desalination.
• ·Chile mining represents 13-14% of GDP and 57% of exports.
• ·Desalination project partnered with BNP Paribas Infrastructure Group; excess water for third-party off-takers.
• ·Copper project is exploration-stage on trend with past-producing Zonia mine (copper oxide).
• ·Post-merger financing for Titanium: 3-4 months after feasibility study, mix of bank, equity, international development corps, possible U.S. government funding.

21-04-2026

MRWM Advisors, LLC filed its 13F-HR on April 21, 2026, for the quarter ended March 31, 2026, disclosing 74 equity holdings with a total market value of $184,447,846, all held with sole voting and disposition power. The portfolio is diversified across ETFs (e.g., Vanguard Total Stock Market ETF at $26,858,213) and large-cap stocks (e.g., Apple Inc. at $5,517,834). No shared power positions or other voting authority reported.

• ·Formerly known as Cypress Capital Advisors, LLC (name change February 28, 2018)
• ·Business address: 1614 16th Avenue South, Nashville, TN 37212
• ·No other managers or shared voting/disposition power reported

21-04-2026

Provectus Biopharmaceuticals, Inc. announced via press release that its 2026 Annual Meeting of Stockholders will be held on June 18, 2026, at Perkins Place, its planned new headquarters in Knoxville, Tennessee. A preliminary proxy statement was filed with the SEC on April 20, 2026, with a record date of the same day, and proxy materials will be made available to stockholders.

• ·Preliminary proxy statement filed with SEC on April 20, 2026
• ·Record date for stockholders: April 20, 2026
• ·Annual Report on Form 10-K for year ended December 31, 2025, filed March 26, 2026

21-04-2026

PAVmed Inc. filed an S-3 registration statement on April 21, 2026, enabling selling stockholders to offer 9,230,786 shares of common stock, which would increase outstanding shares from 7,272,739 (as of April 6, 2026) to 11,888,132 upon full issuance. The company will receive no proceeds from these sales but could obtain up to $30,000,000 if the underlying Warrants are exercised for working capital. The prospectus extensively details risks, including substantial doubt about going concern status, ongoing operating losses, capital-raising difficulties, potential Nasdaq delisting, and significant dilution from future share issuances.

• ·84,169 shares issuable upon exercise of stock options at weighted average price of $197.07 per share.
• ·3,467 shares issuable upon conversion of Series B Preferred Stock at $1,350.00 per share.
• ·33,333 shares issuable upon full conversion of 2026 Note at $450.00 per share.
• ·Common stock trades on Nasdaq Capital Market under symbol 'PAVM'.
• ·No cash dividends intended on common stock.

21-04-2026

Barron's article in this Form 425 filing highlights the 2026 resurgence of quantum computing companies going public via SPAC mergers, including Infleqtion (Feb), Horizon Quantum (Mar), and Xanadu Quantum Technologies (Mar 27) with shares surging 15% on debut, alongside upcoming deals like IQM with Real Asset Acquisition. It features positive comments from Pasqal CEO Wasiq Bokhari on Bleichroeder Acquisition Corp. II's proposed business combination with Pasqal Holding SAS for U.S. capital access, but warns of de-SPAC risks like high redemptions, average 60% stock price drops post-merger over five years, and quantum stocks' volatility with no profitability. IonQ achieved over $100M in annual GAAP revenue in 2025, yet investments remain speculative.

• ·IonQ 52-week trading range: $23.49 low to $84.64 high
• ·Rigetti 52-week trading range: below $8 to above $58
• ·Quantinuum filed confidentially for IPO, potentially as soon as 2026
• ·No quantum de-SPACs in 2025
• ·Citi initiated Infleqtion at Buy; Northland initiated Xanadu at Outperform

21-04-2026

Vernal Capital Acquisition Corp., a Cayman Islands-incorporated blank check company based in Singapore, filed Amendment No. 3 to its S-1 registration statement for a $100,000,000 IPO of units priced at $10.00 each (implying 10,000,000 units), with net proceeds before expenses of $99,482,500 and $100,500,000 to be deposited into a U.S. trust account (or $115,575,000 if over-allotment exercised in full). The company, an emerging growth company with no current operations, plans to pursue an initial business combination within 15 months (extendable to 21 months), but highlights high investment risks including failure to find a suitable target. Underwriting discounts total $517,500, with additional representative and deferred compensation shares issued to D. Boral Capital.

• ·Underwriting discounts: $0.05175 per unit.
• ·Private placement: Vernal One to purchase 213,562 units (85%), Xesse Ventures 37,688 units.
• ·Founder shares subject to up to 375,000 forfeiture if over-allotment not exercised.
• ·Extension deposits: $330,000 per one-month extension ($0.0330 per share).
• ·Listing symbols: VECA (ordinary shares), VECAR (rights) on NYSE.
• ·Fiscal year end: July 31.

21-04-2026

Tumwater Wealth Management, LLC filed its 13F-HR report on April 21, 2026, disclosing total holdings of $248,641,449 across 34 positions as of March 31, 2026. The portfolio is dominated by Dimensional ETF Trust products, including World ex US Core Equity ETF ($72,974,014, 2,148,190 shares), US Targeted Value ETF ($39,264,501, 628,735 shares), and US Large Cap Value ETF ($31,956,843, 894,899 shares), alongside Vanguard ETFs like Total Stock Market ETF ($52,762,979, 164,468 shares). Individual stock positions include Apple Inc ($1,101,530, 4,340 shares) and Chevron Corporation ($2,933,251, 14,177 shares), with all holdings reported as sole discretionary.

• ·Report filed as of April 21, 2026; period end March 31, 2026
• ·All 34 positions held as sole discretionary (SH SOLE) with zero put/call options
• ·Headquartered at 110 W Main St, Boise, ID 83702

21-04-2026

AA Financial Advisors, LLC filed a 13F-HR disclosing holdings in 221 securities with a total market value of $709,887,826,000 as of March 31, 2026. The portfolio features significant allocations to ETFs such as Capital Group Dividend Value ETF ($34.2B), Vanguard Index Fds Small Cp ETF ($33.5B), and Dimensional ETF Trust US Core Equity 2 ($28.8B), alongside individual stocks like Apple Inc., Microsoft Corp., and Nvidia Corporation. All reported positions are held with sole investment discretion and sole voting power.

• ·Filing date: April 21, 2026
• ·Report period end: March 31, 2026
• ·Business address: 150 E Broad St., Suite 100, Columbus, OH 43215
• ·Phone: 614-442-3355
• ·SEC file number: 028-24043
• ·All holdings reported as SH SOLE with sole voting power

21-04-2026

BCU Wealth Advisors, LLC filed its 13F-HR on April 21, 2026, reporting institutional holdings as of March 31, 2026, with a total portfolio value of $268239693 thousand across 60 positions, heavily allocated to Dimensional and iShares ETFs. Top holdings include Dimensional ETF Trust US Core Equity 2 (3058573 shares, value $118856133 thousand), Dimensional ETF Trust Intl Core Equity (1073062 shares, value $38125878 thousand), and Dimensional ETF Trust Emerging Mkts Core Eqy Mkt ETF (346910 shares, value $11985724 thousand). Other significant positions feature Baxter Intl Inc (21145 shares, value $355229 thousand) and various BlackRock ETFs, with no voting authority changes indicated (all DFND 1 0 0).

• ·Filing CIK: 0002003570
• ·SEC File Number: 028-23673
• ·Business Address: 300 N Milwaukee Ave, Vernon Hills, IL 60061
• ·All positions reported as DFND with voting authority sole:1, shared:0, none:0
• ·Conformed period end: 2026-03-31

21-04-2026

Falcon Wealth Planning filed its 13F-HR report disclosing holdings in 236 securities with a total market value of $1,467,878,472 as of March 31, 2026. Notable positions include Karman Holdings Inc. ($205,684,152), American Century ETF TR US Large Cap Value ($158,848,093), Apple Inc. ($71,609,356), and NVIDIA Corporation ($10,612,574). The portfolio is diversified across ETFs, technology, and other equities, with all positions reported as sole discretionary.

• ·Report filed on April 21, 2026, for period ending March 31, 2026.
• ·Business address: 3400 Inland Empire Blvd., Suite 100, Ontario, CA 91764.
• ·All holdings designated as SH SOLE with voting authority primarily sole.

21-04-2026

CID Holdco, Inc. filed definitive additional proxy materials (DEFA14A) attaching a Form 8-K detailing entry into financing agreements with White Lion Capital, LLC on April 17, 2026, including a Common Stock Purchase Agreement for up to $10,000,000 of common stock and a Note Purchase Agreement for up to $2,875,000 principal ($2,300,000 proceeds at 20% OID) in monthly tranches. The agreements require stockholder approval by May 15, 2026, to exceed the Nasdaq 19.99% exchange cap, with $120,000 in commitment shares and potential $250,000 liquidated damages for delays in registration or approval. No operational or financial performance metrics or period-over-period comparisons are provided.

• ·Effective Date of financing agreements: April 17, 2026
• ·CSPA Commitment Period: April 17, 2026 to December 31, 2028
• ·First note tranche closing: within one trading day after SEC registration statement filing
• ·Stockholder record date for proxy materials: March 23, 2026
• ·Notes mature 6 months after each tranche funding date
• ·Notes subordinated to J.J. Astor loan until discharged
• ·Company is an emerging growth company

21-04-2026

Decker Retirement Planning Inc. reported total holdings valued at $220,723,730 across 284 positions as of March 31, 2026, in its 13F-HR filing submitted April 21, 2026. The portfolio emphasizes ETFs, with the largest position in iShares 0-3 Month Treasury ETF at $38,607,255 (18% of total), followed by Invesco Solar ETF ($9,745,295) and J.P. Morgan Equity Premium Income ETF ($8,021,024). All reported holdings are held with sole voting power, reflecting a diversified mix of fixed income, equity, and thematic investments including semiconductors like Photronics Inc. ($3,935,328).

• ·Filing Date: April 21, 2026
• ·Report Period End: March 31, 2026
• ·CIK: 0001975700
• ·Business Address: 2889 W. Ashton Blvd. Suite 125, Lehi, UT 84043
• ·Business Phone: 855-425-4566
• ·All holdings reported with sole investment discretion and voting power

21-04-2026

Plutonian Acquisition Corp. II, a SPAC, filed an S-1/A on April 20, 2026, for an IPO of 10,000,000 units at $10.00 each, with 210,000 private units purchased by the sponsor for $2,100,000, resulting in 10,210,000 units outstanding (up to 11,725,600 if over-allotment exercised in full). $100,500,000 ($10.05 per unit) will be deposited into a trust account (up to $115,575,000 if full over-allotment), held until a business combination within 12 months or redemption. No operational performance data is available as this is a pre-IPO blank-check company filing.

• ·Rights entitle holders to 1/4 ordinary share upon business combination (must hold multiples of 4; no fractional shares).
• ·Initial shares subject to 180-day lock-up post-business combination, with early release triggers at $12.00 share price.
• ·Private units identical to public units; sponsor commits to vote in favor of business combination.
• ·Sponsor may purchase up to 225,600 additional private units if over-allotment exercised.

21-04-2026

Delek US Holdings, Inc. announced the appointment of Amber Russell as Executive Vice President, Refining, effective April 20, 2026, succeeding Joseph Israel, who is departing after contributions to operational excellence. Ms. Russell brings nearly three decades of experience from ExxonMobil and bp, including senior roles in refining, terminals, and pipelines. Avigal Soreq, President and CEO, highlighted her expertise as key to strengthening Delek's refining platform.

• ·Ms. Russell will be based at Delek’s Brentwood, Tennessee office and report directly to Avigal Soreq.
• ·Announcement dated April 20, 2026; SEC filing April 21, 2026.

21-04-2026

Amesite Inc. furnished presentation materials via 8-K detailing NurseMagic's AI-native documentation platform targeting the $1.5T non-acute care market, including hospice ($29.9B), home health ($162.4B), home care ($173.6B), skilled nursing ($199.7B), and senior living ($943.9B). Q2 2026 revenues reached $108,050, up 240% QoQ, with current revenue mix at 39% B2C and 61% B2B, and the company anticipates profitability at 10-20 new large customers or less than $5M annual revenue. Positive testimonials, 49K+ social followers, and a sales pipeline of 15 organizations (~62,000 census) support B2B growth targeting multi-site operators.

• ·Sales pipeline includes ~50K individual prospects and ~1K organizations from marketing, expanding to ~200K prospects and ~7K organizations.
• ·B2B sales cycle anticipated at 30-90 days based on current prospects.
• ·Positive testimonials highlight documentation efficiency for RNs, staff, and caregivers.
• ·Brand reach: 1.1M accounts reached in last 90 days across 6 social channels with multiple viral posts over 1M views.

21-04-2026

On April 20, 2026, lenders under Inotiv, Inc.'s Credit Agreement (dated November 5, 2021) granted a limited waiver of the minimum liquidity covenant specifically for the April 17, 2026 and April 24, 2026 liquidity test dates. No provisions of the Credit Agreement were amended by this waiver. The event highlights potential short-term liquidity covenant compliance issues at the company.

• ·Credit Agreement originally dated November 5, 2021, among Inotiv, Inc., certain subsidiaries, and lenders party thereto.

21-04-2026

Cadrenal Therapeutics, Inc. filed an S-3 shelf registration statement on April 21, 2026, for the resale of 1,180,003 shares of common stock by selling stockholders, including shares issuable upon exercise of investor and placement agent warrants. This follows a March 31, 2026, warrant inducement agreement where an investor exercised existing warrants for 571,430 shares at a reduced price of $4.50 per share (from $16.50), providing cash inflow to the company in exchange for new Series B-1 and B-2 warrants each covering 571,430 shares. The filing coincides with positive regulatory progress, including a successful End-of-Phase 2 FDA meeting on March 26, 2026, for lead candidate CAD-1005, though products remain unapproved and face clinical development risks.

• ·Orphan Drug Designation (ODD) from FDA for CAD-1005 prophylaxis of thrombosis in HIT patients
• ·FDA Fast Track designation for CAD-1005 treatment and prevention of HIT
• ·EMA orphan designation for platelet-activating factor 4 disorders
• ·Company qualifies as Emerging Growth Company and Smaller Reporting Company
• ·Principal executive offices: 822 A1A North, Suite 306, Ponte Vedra, Florida 32082

21-04-2026

News Corporation filed an 8-K disclosing information provided to the Australian Securities Exchange (ASX) regarding its ongoing $1 billion stock repurchase program for Class A (NWSA) and Class B (NWS) common stock, as attached in Exhibits 99.1 and 99.2. The program authorizes repurchases from time to time, with daily disclosures required by ASX rules if transactions occur. No specific repurchase transactions are detailed in the filing.

• ·Filing date: April 21, 2026; Earliest event date: April 20, 2026
• ·Securities: Class A Common Stock (NWSA) and Class B Common Stock (NWS) on Nasdaq Global Select Market

21-04-2026

Onto Innovation announced a strategic partnership with Rigaku to advance X-ray process control solutions for advanced V-NAND, DRAM, logic, and memory, integrating its Ai Diffract™ software with Rigaku’s CD-SAXS platforms, which has been selected by two key customers targeting a market estimated in excess of $1 billion within five years. The company entered a definitive agreement to acquire 27% of Rigaku’s outstanding common stock for $710 million from an affiliate of The Carlyle Group, gaining board nomination rights, with the deal expected to close in H2 2026 and be accretive by December 31, 2026. No declines or flat metrics reported.

• ·Transaction subject to customary closing conditions including regulatory approvals
• ·Onto Innovation to account for investment under fair value option method without consolidation
• ·Right to nominate one director to Rigaku’s board upon closing
• ·Expected closure in second half of 2026
• ·Advisors: Greenhill (financial), Goldman Sachs (financing), Simpson Thacher & Bartlett LLP and Nishimura & Asahi (legal) for Onto

21-04-2026

Independent Wealth Network Inc. (CIK: 0001891240) filed a 13F-HR on April 21, 2026, disclosing $336706849 in total holdings as of March 31, 2026, across 301 positions, all held on a sole discretionary basis. Top holdings include Caterpillar Inc. at $18503350 (26118 shares), JPMorgan Exchange-Traded F Ultra Shrt ETF at $12648282 (249917 shares), and iShares Silver Tr Ishares at $7207686 (105778 shares). This filing provides a snapshot of portfolio composition with no period-over-period changes reported.

• ·Business address: 2350 NW 128TH ST., URBANDALE, IA 50323
• ·Phone: 515-461-5123
• ·SEC file number: 028-21395
• ·All holdings reported as SH SOLE with 0 SH PRN, 0 SH SHRD, 0 OTHER

21-04-2026

Collective Acquisition Corp. II, a blank check company focused on real estate and construction, filed Amendment No. 1 to its S-1 registration statement (No. 333-294701) on April 20, 2026, for an IPO of 22,000,000 units. The sponsor acquired 8,433,333 Class B founder shares for $25,000 ($0.003 per share), representing approximately 24.9% ownership post-offering on an as-converted basis. Post-IPO (assuming no over-allotment), ordinary shares will total 29,498,333 and warrants 15,670,000, with warrants exercisable at $11.50 per share starting 30 days after a business combination.

• ·Separate trading of Class A shares and warrants prohibited until Form 8-K filed with audited balance sheet post-closing.
• ·Each unit contains one Class A ordinary share and one-half of one warrant; only whole warrants trade.
• ·Warrants expire 5 years after business combination or earlier upon redemption/liquidation.
• ·Redemption of warrants possible at $0.01 each if Class A share price >= $18.00 for 20 trading days in 30-day period.
• ·Founder shares convertible to Class A on 1:1 basis post-business combination, subject to anti-dilution.
• ·Up to 1,100,000 founder shares surrender if over-allotment not fully exercised.

21-04-2026

Opus Genetics, Inc. filed an S-3/A amendment to register for resale up to 7,374,632 shares of common stock by selling stockholders, issuable upon automatic conversion of an equal number of Series B Non-Voting Convertible Preferred Stock from a private placement that closed on February 18, 2026, at $3.39 per share. The company will not receive proceeds from these resales, which are intended to satisfy registration rights obligations. Common stock trades on Nasdaq under 'IRD' with a last reported sale price of $5.75 on April 17, 2026.

• ·Private Placement securities purchase agreement entered February 13, 2026; stockholder approval obtained for authorized common shares increase to permit conversion.
• ·Series B Preferred Stock converts automatically on or about April 23, 2026, subject to beneficial ownership limitations.
• ·Registrant classified as non-accelerated filer and smaller reporting company.
• ·Principal executive offices: 8 Davis Drive, Suite 220, Durham, NC 27713; phone (248) 957-9024.

21-04-2026

Prelude Therapeutics Incorporated (Nasdaq: PRLD) announced the pricing of an underwritten public offering of 18,018,014 shares of common stock at $4.44 per share and pre-funded warrants to purchase up to 2,252,252 shares at $4.4399 per warrant, expecting gross proceeds of approximately $90.0 million before expenses. The offering, led by new investor RA Capital Management with participation from Soleus Capital and others, is anticipated to close on or about April 21, 2026, with net proceeds allocated to general corporate purposes including research, preclinical, and clinical development of product candidates. No declines or flat metrics were reported in this financing announcement.

• ·Registration statement on Form S-3 filed with SEC on May 30, 2024, declared effective June 10, 2024.
• ·Offering joint book-running managers: Goldman Sachs & Co. LLC, Evercore ISI, Citizens Capital Markets.

21-04-2026

CrowdStrike's Board approved a performance- and service-based equity award of 100,000 target PSUs to President Michael Sentonas under the 2019 Equity Incentive Plan, tied to the company's TSR relative to S&P 500 companies over a three-year period from December 22, 2025, to December 22, 2028, with potential payout from 0 to 200,000 shares based on percentile rankings (50% at 25th percentile threshold, 200% at 90th+). The award recognizes Sentonas's role in driving revenue growth from $3.06B in FY2024 to $4.81B in FY2026 and ARR from $3.44B to $5.25B, alongside a 300% stock return ranking in the 95th percentile of S&P 500 over three years. It aligns incentives with the ambition to reach $20B in ending ARR amid expansions in high-growth markets and strategic acquisitions.

• ·PSU payout levels: 200% at 90th+ percentile TSR, 150% at 75th, 100% at 55th, 50% at 25th, 0% below 25th
• ·Earned PSUs subject to additional one-year service vesting (25% quarterly on Mar 20, Jun 20, Sep 20, Dec 20, 2029)
• ·Performance period: December 22, 2025 to December 22, 2028
• ·Award approved April 16, 2026

21-04-2026

Grey Ledge Advisors, LLC disclosed total holdings of $442,992,213 across 239 securities in its 13F-HR filing as of March 31, 2026. The portfolio is diversified with significant allocations to ETFs such as Harbor International Compounders ETF ($11,158,009) and PIMCO Multisector Bond Active Exchange-Traded Fund ($12,347,591), alongside individual stocks like Apple Inc. and NVIDIA Corporation. No prior period comparisons or changes are provided in this routine quarterly snapshot.

• ·Filing date: April 21, 2026
• ·Report period end: March 31, 2026
• ·All reported holdings held with sole voting and dispositive power

21-04-2026

Morton Brown Family Wealth, LLC disclosed 292 equity positions totaling $378,411,780 in its 13F-HR filing for the quarter ended March 31, 2026. The portfolio features heavy ETF allocations, led by SCHWAB U.S. BROAD MARKET ETF at $100,848,498 (4,017,868 shares), AVANTIS EMERGING MARKETS EQUITY ETF at $37,494,580 (465,309 shares), and iShares National Muni Bond ETF at $18,613,984 (175,355 shares). Individual stocks like Apple Inc. ($2,178,534, 8,584 shares) and NVIDIA Corporation ($618,522, 3,547 shares) represent smaller but notable positions, with no reported changes or performance metrics.

• ·All positions held as sole discretionary with zero put/call options or other manager shares.
• ·Firm based in Allentown, PA.
• ·Filing covers period ended March 31, 2026, submitted April 21, 2026.

21-04-2026

Coronado Global Resources Inc. filed an 8-K under Regulation FD Disclosure, announcing that it lodged an ASX announcement on April 20, 2026, regarding an upcoming investor conference call on April 27, 2026 (April 28, 2026 in Australia). The announcement is attached as Exhibit 99.1, with direct call link details provided. No financial or operational metrics were disclosed.

• ·Direct link to conference call: https://s1.c-conf.com/diamondpass/10053845-e8cjhi.html
• ·Filing date: April 21, 2026; Earliest event date: April 20, 2026

21-04-2026

Verus Financial Partners, Inc., based in Richmond, VA, filed its 13F-HR disclosing $1,114,955,862 in total holdings across 121 positions as of March 31, 2026. The portfolio is diversified with heavy emphasis on passive ETFs, led by Vanguard Total Stock Market (267780264 value) and Vanguard Total Bond Market (131527459 value), alongside Dimensional and iShares funds. No prior period data is provided in the filing.

• ·Filing Date: April 21, 2026
• ·Report Period End: March 31, 2026
• ·State of Incorporation: VA
• ·SEC File Number: 028-13642
• ·Former Name: Kuehl Shepherd Kozlowski & Associates, Inc. (name change 2010-01-21)

21-04-2026

Allbirds, Inc. released preliminary unaudited financial results for Q1 ended March 31, 2026, showing net revenue of $22,321 thousand, gross profit of $6,208 thousand at a 27.8% margin, but high operating expenses of $27,112 thousand led to a net loss of $19,589 thousand and Adjusted EBITDA loss of $16,067 thousand. Cash and cash equivalents were $14.4 million as of quarter-end. These figures are preliminary and subject to material adjustments upon finalization.

• ·Figures are unaudited preliminary estimates +/- specified ranges (e.g., revenue +/- $1.0M, net loss +/- $3.0M) and subject to material changes during quarter-end procedures.

21-04-2026

LifeWealth Investments, LLC filed a 13F-HR on April 21, 2026, disclosing its institutional holdings as of March 31, 2026, with a total portfolio value of $335042535 across 141 positions, all held as sole ownership. The largest holding is iShares Russell Top 200 Growth ETF valued at $32926892 (132322 shares), followed by iShares Russell Top 200 Value ETF at $21180188 (228555 shares) and Capitol Series Trust Sterling Capital Enhanced Equity at $19138773 (762957 shares). No period-over-period changes are disclosed in this filing.

• ·All positions held as sole ownership (SH SOLE) with no shared, other, or none voting rights indicated.
• ·Firm address: 270 W. PLANT STREET, STE. 240, WINTER GARDEN, FL 34787.
• ·SEC file number: 028-25415; CIK: 0002033794.

21-04-2026

Pegasus Asset Management, Inc. disclosed total holdings of $312,758,568 across 67 positions in its 13F-HR filing as of March 31, 2026, with all positions held under sole voting power. Top holdings by value include Schwab Strategic Tr US Brd Mkt ETF ($29,132,052), Apple Inc ($20,885,019), Alphabet Inc Cap Stk Cl C ($16,965,188), NVIDIA Corp ($14,230,737), and Microsoft Corp ($13,479,371). The report was filed on April 21, 2026.

• ·All holdings reported with sole voting power (SH SOLE) and no shared or other voting power.
• ·Date as of change: 04-20-2026
• ·Business address: 44 Whippany Road, Suite 101, Morristown, NJ 07960

21-04-2026

For the three months ended February 28, 2026, Black Hawk Acquisition Corp reported net income of $139,805, down 79% YoY from $658,379, primarily due to sharply lower interest earned on Trust Account investments ($213,442 vs. $765,911) despite improved operating loss ($54,189 vs. $108,769). Cash and cash equivalents increased to $178,407 from $39,521 at period start, bolstered by $848,388 in financing inflows including from related parties and target company, while the Trust Account grew to $24.6 million. However, shareholders' deficit widened to $(4,520,080) from $(3,846,443), reflecting remeasurement adjustments.

• ·Trust Account investments measured at Level 1 fair value.
• ·Supplemental non-cash: Change in value of Class A shares subject to redemption $813,442 (2026) vs. $765,911 (2025).
• ·Proceeds from target company: $440,988.
• ·G&A expenses declined to $24,189 from $78,769; related party fees flat at $30,000.

21-04-2026

Up Capital Management, Inc. disclosed total holdings of $89,148,360 across 18 positions in its 13F-HR filing as of March 31, 2026. The portfolio features significant allocations to technology stocks and ETFs, with top holdings NVIDIA Corporation ($25,259,137), Vanguard S&P 500 ETF ($12,663,707), and Invesco QQQ Trust ($7,827,915). No period-over-period changes are provided in the filing.

• ·Filing period end date: March 31, 2026
• ·Filing date: April 21, 2026
• ·All holdings reported as sole voting authority (SH SOLE)

21-04-2026

Chatham Capital Group, Inc. disclosed 198 equity holdings totaling $689326196 as of March 31, 2026, in its 13F-HR filing submitted April 21, 2026. The portfolio, all under sole voting authority, features a mix of individual stocks and ETFs, with top positions including Vanguard Index Fds Small Cp ETF ($31302321), NVIDIA Corporation ($29363417), and iShares Gold Tr ($28563399). No period-over-period changes are indicated in this snapshot report.

• ·Filing covers period ending March 31, 2026 (Q1 2026)
• ·All 198 holdings reported as sole discretionary voting authority with zero shared or other authority